This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Apr;39(4):403-404.

doi: 10.1038/s41587-021-00892-w.

Reply to: Democratizing biotechnology requires more than availability

Shawn S Jackson¹, Louise E Sumner², Rocco J Casagrande²

Affiliations

PMID: 33772257
DOI: 10.1038/s41587-021-00892-w

Comment

Reply to: Democratizing biotechnology requires more than availability

Shawn S Jackson et al. Nat Biotechnol. 2021 Apr.

. 2021 Apr;39(4):403-404.

doi: 10.1038/s41587-021-00892-w.

Authors

Shawn S Jackson¹, Louise E Sumner², Rocco J Casagrande²

Affiliations

¹ Gryphon Scientific, LLC, Takoma Park, MD, USA. froggi@gryphonscientific.com.
² Gryphon Scientific, LLC, Takoma Park, MD, USA.

PMID: 33772257
DOI: 10.1038/s41587-021-00892-w

No abstract available

PubMed Disclaimer

Comment on

The accelerating pace of biotech democratization.
Jackson SS, Sumner LE, Garnier CH, Basham C, Sun LT, Simone PL, Gardner DS, Casagrande RJ. Jackson SS, et al. Nat Biotechnol. 2019 Dec;37(12):1403-1408. doi: 10.1038/s41587-019-0339-0. Nat Biotechnol. 2019. PMID: 31796931 No abstract available.
Democratizing biotechnology requires more than availability.
Beumer K. Beumer K. Nat Biotechnol. 2021 Apr;39(4):403. doi: 10.1038/s41587-021-00890-y. Nat Biotechnol. 2021. PMID: 33772256 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- scite Smart Citations